Safeguard Scientifics, Inc.
SFES · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.05 | -0.00 | 0.10 |
| FCF Yield | 0.00% | 0.00% | -2.10% | 0.00% |
| EV / EBITDA | 5.56 | -9.50 | -1.63 | -6.63 |
| Quality | ||||
| ROIC | -5.75% | -5.25% | -4.18% | -3.47% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.05 | 0.51 | 0.74 | 0.19 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -6.18 | 7.59 | 1.18 | 5.21 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |